For clinical decision-making carbapenemase production should be detected using:
A)MALDI-TOF mass spectrometry.
B)Modified Hodge test or Carba NP test.
C)molecular methods for specific carbapenemases.
D)routine AST methods using current CLSI interpretive criteria.

Question

Quizplus · Accepted Answer

Current CLSI interpretive criteria are sufficient to detect carbapenem resistance to the carbapenem agents in clinical use at this time.For epidemiologic or research studies or if interpretive guidelines from 2010 or prior are used then Modified Hodge test or Carba NP tests,MALDI-TOF,or molecular methods can be used to confirm the presence of carbapenemase activity or specific carbapenemase genes.

For Clinical Decision-Making Carbapenemase Production Should Be Detected Using